Boston Therapeutics, Inc. — Form D

Boston Therapeutics, Inc. of LAWRENCE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2013-08-07. The offering totals $8.0M, of which $2.0M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (23)

NameRoleLocation
Dale H ConawayDirectorNewton, MA
Rom H EliazDirectorManchester, NH
Henry H EsberDirectorManchester, NH
Carl H LuedersDirectorManchester, NH
David Platt, Ph. D.DirectorManchester, NH
Kenneth Tassey, Jr.DirectorManchester, NH
David Platt, Ph. D.Executive OfficerManchester, NH
Kenneth Tassey, Jr.Executive OfficerManchester, NH
David Platt, Ph. D.PromoterManchester, NH
Kenneth Tassey, Jr.PromoterManchester, NH
David PlattDirectorAtglen, PA
David PlattExecutive OfficerAtglen, PA
Conroy Chi-Heng ChengDirectorLawrence, MA
David LudvigsonDirectorLawrence, MA
David LudvigsonExecutive OfficerLawrence, MA
Colin W NeillDirectorLawrence, MA
Carl W RauschExecutive OfficerLawrence, MA
Alan W HobermanDirectorLawrence, MA
Rom W EliazDirectorLawrence, MA
Henry W EsberDirectorManchester, NH
Dale W ConwayDirectorManchester, NH
Kenneth A Tassey, Jr.DirectorManchester, NH
Kenneth A Tassey, Jr.Executive OfficerManchester, NH

Other filings by this issuer (4)

FiledFormOfferingSold
2021-07-09D$8.4M$8.4M
2016-09-20D/A$2.0M$1.6M
2016-08-25D$2.0M$1.3M
2011-07-05D$508K$508K

More